AEON Biopharma (AEON) Net Income (2021 - 2026)
AEON Biopharma (AEON) posted Net Income of -$37.1 million for Q4 2025, down 718.36% sequentially from -$4.5 million in Q3 2025, and down 1540.37% YoY from $2.6 million in Q4 2024.
AEON Biopharma (AEON) Net Income (2021 - 2026) Analysis & Trends
AEON Biopharma has reported Net Income for 5 years, with the latest figure at -$37.1 million in Q4 2025.
- Quarterly Net Income fell 1540.37% year-over-year to -$37.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$39.2 million (down 192.28% YoY) and the FY2025 annual result came in at -$31.0 million, down 173.77% from the prior year.
- Net Income declined to -$37.1 million in Q4 2025 per AEON's latest filing, from -$4.5 million in the prior quarter.
- Over five years, Net Income peaked at $164.1 million in Q2 2024 and troughed at -$297.7 million in Q3 2023.
- A 5-year average of -$19.3 million and a median of -$4.5 million in 2025 frame the typical range for Net Income.
- The widest YoY moves for Net Income: up 1540.39% in 2022, down 14043.78% in 2022.
- Over 5 years, Net Income stood at $247874.0 in 2021, then slumped by 14043.78% to -$34.6 million in 2022, then sank by 761.36% to -$297.7 million in 2023, then soared by 100.87% to $2.6 million in 2024, then sank by 1540.37% to -$37.1 million in 2025.
- According to Business Quant data, Net Income over the past three periods registered -$37.1 million, -$4.5 million, and -$6.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 482.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 164.49 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -355.03 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -13.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 81.49 Mn |
| 10 | AEON Biopharma | 9.71 Mn | 6.28 Mn | - | -1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.16 Mn |
| Dec 31, 2025 | -37.14 Mn |
| Sep 30, 2025 | -4.54 Mn |
| Jun 30, 2025 | -6.64 Mn |
| Mar 31, 2025 | 9.10 Mn |
| Dec 31, 2024 | 2.58 Mn |
| Sep 30, 2024 | -6.17 Mn |
| Jun 30, 2024 | 164.11 Mn |
| Mar 31, 2024 | -118.02 Mn |
| Sep 30, 2023 | -297.71 Mn |
| Jun 30, 2023 | -15.47 Mn |
| Mar 31, 2023 | -18.04 Mn |
| Dec 31, 2022 | -34.56 Mn |
| Sep 30, 2022 | -10.44 Mn |
| Jun 30, 2022 | 1.87 Mn |
| Mar 31, 2022 | 2.77 Mn |
| Dec 31, 2021 | 247,874.00 |
| Sep 30, 2021 | 5.66 Mn |
| Jun 30, 2021 | -4.03 Mn |
| Mar 31, 2021 | -192,544.00 |